Directorate Change
Novacyt S.A. announced that Dr. Joanne Mason is stepping down as Chief Scientific Officer and a member of the Board of Directors, effective immediately, to pursue other business ventures. The company expressed gratitude for her six-year tenure, during which she was instrumental in shaping the scientific direction and research and development foundations.
Select text to share a quote on X · sign in to keep highlights & notes in your NCYT notes
Paris, France and Manchester, UK - 7 May 2026 - Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces that Dr Joanne Mason is stepping down as Chief Scientific Officer and a member of the Board of Novacyt, with immediate effect, to enable her to pursue other business opportunities.
Lyn Rees, Chief Executive Officer of Novacyt, commented: "Throughout Jo's six-year tenure, she has been instrumental in shaping our scientific direction and strengthening the foundations of our research and development work. Her leadership and expertise have made a meaningful impact, and we are grateful for the dedication she has shown to the organisation. We thank Jo for her contribution to the business and wish her every success in the future."
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.